BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29359812)

  • 21. Intravascular large B-cell lymphoma secondary to lymphoplasmacytic lymphoma: a case report and review of literature with clonality analysis.
    Tanaka Y; Kobayashi Y; Maeshima AM; Oh SY; Nomoto J; Fukuhara S; Kitahara H; Munakata W; Suzuki T; Maruyama D; Tobinai K
    Int J Clin Exp Pathol; 2015; 8(3):3339-43. PubMed ID: 26045864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy.
    Sircar A; Chowdhury SM; Hart A; Bell WC; Singh S; Sehgal L; Epperla N
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microenvironment signaling driving lymphomagenesis.
    Verdière L; Mourcin F; Tarte K
    Curr Opin Hematol; 2018 Jul; 25(4):335-345. PubMed ID: 29746265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
    Martinez D; Navarro A; Martinez-Trillos A; Molina-Urra R; Gonzalez-Farre B; Salaverria I; Nadeu F; Enjuanes A; Clot G; Costa D; Carrio A; Villamor N; Colomer D; Martinez A; Bens S; Siebert R; Wotherspoon A; Beà S; Matutes E; Campo E
    Am J Surg Pathol; 2016 Feb; 40(2):192-201. PubMed ID: 26426381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic clonal evolution: A selection-centric perspective.
    Scott J; Marusyk A
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The basis and rational use of molecular genetic testing in mature B-cell lymphomas.
    Roullet M; Bagg A
    Adv Anat Pathol; 2010 Sep; 17(5):333-58. PubMed ID: 20733353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
    Kubuschok B; Trepel M
    Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
    Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
    PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy.
    Beielstein AC; Pallasch CP
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single Cell Genomics for Tumor Heterogeneity.
    Lee HO; Park WY
    Adv Exp Med Biol; 2021; 1187():205-214. PubMed ID: 33983580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq.
    Giannuzzi D; Marconato L; Cascione L; Comazzi S; Elgendy R; Pegolo S; Cecchinato A; Bertoni F; Aresu L; Ferraresso S
    PLoS One; 2019; 14(4):e0215154. PubMed ID: 31017932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric-type Follicular Lymphoma and Pediatric Nodal Marginal Zone Lymphoma: Recent Clinical, Morphologic, Immunophenotypic, and Genetic Insights.
    Koo M; Ohgami RS
    Adv Anat Pathol; 2017 May; 24(3):128-135. PubMed ID: 28277421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant.
    Flossbach L; Holzmann K; Mattfeldt T; Buck M; Lanz K; Held M; Möller P; Barth TF
    Int J Cancer; 2013 Feb; 132(3):E116-27. PubMed ID: 22890838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetics and Cytogenomics Evaluation in Cancer.
    Ribeiro IP; Melo JB; Carreira IM
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
    Glass S; Phan A; Williams JN; Flowers CR; Koff JL
    Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels.
    Roider T; Seufert J; Uvarovskii A; Frauhammer F; Bordas M; Abedpour N; Stolarczyk M; Mallm JP; Herbst SA; Bruch PM; Balke-Want H; Hundemer M; Rippe K; Goeppert B; Seiffert M; Brors B; Mechtersheimer G; Zenz T; Peifer M; Chapuy B; Schlesner M; Müller-Tidow C; Fröhling S; Huber W; Anders S; Dietrich S
    Nat Cell Biol; 2020 Jul; 22(7):896-906. PubMed ID: 32541878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
    Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M
    Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes.
    Xu B; Wang T
    Tumour Biol; 2017 Jun; 39(6):1010428317706227. PubMed ID: 28618932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.